Parikh Shamik J 4
4 · Humacyte, Inc. · Filed Apr 5, 2022
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Parikh Shamik J
Chief Medical Officer
Transactions
- Award
Stock Options (right to buy)
2022-04-04+144,927→ 144,927 totalExercise: $6.90From: 2023-04-04Exp: 2032-04-04→ Common Stock (144,927 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on April 4, 2023, after which 1/48 of the option will become exercisable on the 4th of each month through August 4, 2026.